~48 spots leftby Apr 2026

QBSafe for Type 2 Diabetes

Recruiting in Palo Alto (17 mi)
Overseen byKasia Lipska, MD MHS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Yale University
No Placebo Group

Trial Summary

What is the purpose of this trial?

Glycemic control is often the main indicator of successful diabetes care, but a singular focus on glycemic control may lead to patients' overall health and wellbeing being overlooked or undervalued. The investigators have previously developed an intervention comprised of (a) a set of conversation cards designed to enable patients to identify aspects of life with diabetes important to them and to share them with their clinician to obtain their input; and (b) materials that help clinicians respond to patient concerns. The investigators will now conduct a randomized clinical trial to test the feasibility of the research procedures and efficacy of the intervention with respect to patient reported outcome measures.

Eligibility Criteria

This trial is for English or Spanish-speaking adults with Type 2 Diabetes who have an HbA1c level over 8%. It's open to patients able to give informed consent and healthcare providers involved in diabetes care. People with a life expectancy that makes higher HbA1c levels acceptable aren't eligible.

Inclusion Criteria

Participants able to sign informed consent
I am a healthcare professional involved in managing type 2 diabetes.
I have been diagnosed with type 2 diabetes.
See 2 more

Exclusion Criteria

My doctor and I agree that an HbA1c target above 8% is suitable for me.

Treatment Details

Interventions

  • QBSafe (Behavioral Intervention)
Trial OverviewThe QBSafe intervention, which includes conversation cards for patients to discuss their diabetes-related concerns and materials aiding clinicians' responses, is being tested for its impact on patient-reported outcomes.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: QBSafe interventionExperimental Treatment1 Intervention
Group II: usual careActive Control1 Intervention

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Fair Haven Community Health CenterNew Haven, CT
Loading ...

Who Is Running the Clinical Trial?

Yale UniversityLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator

References